IPO Date: Nov 7 to Nov 11 2025
Listing Date: Nov 14 2025
i.Capital Expenditure towards Upgradation/Improvement of our existing Manufacturing Facilities;ii.Capital Expenditure towards Construction of a Storage Facility;iii.Pre-payment/Repayment of outstanding Secured Loans;iv.Product Registrations in other countries;v.Funding our Working Capital Requirements; andvi.General Corporate Purpose.
...
tract Manufacturing and own brand marketing basis. Our business is majorly on principle to principlebasis with different marketers. As on the date of this Draft Red Herring Prospectus, we cater to more than 100 corporateclients on loan license and/or contract manufacturing basis along with 2 clients for own brand marketing globally ofRepublic of Yemen and Kenya. Our company has commenced manufacturing facility in year 2017, hence, our companyhas experience of more than 5 years in the current line of business of the company. as on the date of this Draft Red HerringProspectus our manufacturing facility at Curis Lifesciences Limited is installed with capacity to manufacture 138 Croretables / year, 15.75 Crore Capsules / year, 1080 Kilolitre Oral Liquid/ year, 270 Tons external preparation / year and 45Tons sterile ophthalmic ointment / year. Our promoters have a vast experience in the pharmaceutical manufacturingIndustry. Driven by the passion for building an integrated pharmaceutical company, backed by their experience, ourPromoters have been the pillars of our Company's growth and have built a strong value system for our Company. Withtheir enriching experience and progressive thinking, we aim to continue to grow in the pharmaceutical industry Read MoreMUFG Intime India Pvt Ltd.
Posted on Dec 24th
Rahul Gandhi accuses BJP of empowering monopolies, burdening small traders
Posted on Dec 24th
DB (International) Stock Brokers informs about disclosure
Posted on Dec 24th
E to E Transportation Infrastructure coming with IPO to raise Rs 84 crore
Posted on Dec 24th
Currency futures for December expiry trade weaker with 0.98% increase in OI
The issue size of Curis Lifesciences Ltd. IPO is ₹18.49 - 19.72 crore.
The Curis Lifesciences Ltd. IPO opens for subscription on 2025-11-07 and closes on 2025-11-11.
The price range of Curis Lifesciences Ltd. IPO is ₹120.00 to ₹128.00.
The lot size of Curis Lifesciences Ltd. IPO is 2000 shares.
The registrar of Curis Lifesciences Ltd. IPO is MUFG Intime India Pvt Ltd..
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.